- Investing Ideas
- /
- U.S. Large Cap High Growth Potential
U.S. Large Cap High Growth Potential
Results
247
13 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
247 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ALNY | US$271.31 | -2.0% | 58.9% | US$35.0b | US$299.74 | PS16.7x | E56.7% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$198.22 | 4.3% | 59.2% | US$62.1b | US$195.00 | PE92.6x | E38.4% | 1.9% | Diversified Financials | ||
NVDA | US$120.07 | 1.4% | 73.2% | US$2.9t | US$173.78 | PE46.6x | E21.8% | 0.03% | Semiconductors | ||
ONON | US$59.88 | -0.03% | 120.4% | US$19.2b | US$62.47 | PE138.6x | E29.7% | n/a | Consumer Durables | ||
NU | US$13.24 | 7.5% | 42.8% | US$63.6b | US$15.06 | PB8.3x | E25.2% | n/a | Banks | ||
MRVL | US$112.86 | 12.5% | 68.4% | US$97.7b | US$129.25 | PS18.2x | E55.6% | 0.2% | Semiconductors | ||
ITCI | US$127.08 | -0.1% | 84.2% | US$13.5b | US$128.64 | PS22x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
SMCI | US$28.52 | -1.9% | -57.0% | US$16.7b | US$40.79 | PE13.8x | E24.3% | n/a | Tech | ||
KSPI | US$95.10 | -1.8% | 4.7% | US$18.1b | US$126.60 | PE9.6x | E20.8% | 6.9% | Diversified Financials | ||
PLTR | US$82.49 | 9.3% | 393.4% | US$187.9b | US$53.42 | PE394.3x | E28.7% | n/a | Software | ||
SN | US$111.81 | 0.2% | 134.6% | US$15.7b | US$122.87 | PE43.6x | E22.4% | n/a | Consumer Durables | ||
CRDO | US$70.02 | 25.9% | 228.6% | US$11.7b | US$79.54 | PS47.7x | E66.2% | n/a | Semiconductors | ||
CVNA | US$247.48 | 2.2% | 465.0% | US$52.3b | US$253.41 | PE1870.8x | E37.2% | n/a | Retail | ||
SRPT | US$113.72 | -2.7% | -9.4% | US$10.9b | US$185.16 | PE89.2x | E29.8% | n/a | Pharmaceuticals & Biotech | ||
VRT | US$117.02 | 14.1% | 90.0% | US$43.9b | US$143.31 | PE75.5x | E26.8% | 0.1% | Capital Goods | ||
EXE | US$101.60 | 0.2% | 34.8% | US$23.5b | US$117.54 | PE92.4x | E64.0% | 2.3% | Energy | ||
SPOT | US$548.55 | 6.7% | 145.7% | US$110.9b | US$497.39 | PE152.5x | E26.6% | n/a | Media | ||
CTRA | US$27.72 | -0.4% | 14.6% | US$20.4b | US$34.59 | PE16.5x | E25.2% | 3.0% | Energy | ||
NTNX | US$68.77 | 9.2% | 19.9% | US$18.4b | US$81.89 | PS8.3x | E92.0% | n/a | Software | ||
ZS | US$202.59 | 5.9% | -12.7% | US$31.1b | US$226.04 | PS13.5x | E39.7% | n/a | Software | ||
RYAN New | US$66.58 | 1.9% | 56.4% | US$17.4b | US$73.98 | PE81.9x | E43.9% | 0.7% | Insurance | ||
XPEV | US$15.22 | 0.9% | 93.4% | US$14.4b | US$14.77 | PS2.8x | E56.7% | n/a | Automobiles | ||
DASH | US$188.83 | 3.5% | 74.6% | US$78.4b | US$186.03 | PS7.7x | E44.0% | n/a | Consumer Services | ||
WIX | US$238.89 | 1.9% | 86.7% | US$13.4b | US$238.93 | PE143.4x | E32.1% | n/a | Software |